THE RESULT OF STUDIES OF CLINICAL AND NEUROLOGICAL COMPLICATIONS IN PATIENTS WITH POLYNEUROPATHIES OF THE ETIOLOGY COVID-19

Most people who fall sick with COVID-19 will experience mild to moderate symptoms and recover without special treatment. However, some will become seriously ill and require medical attention. Coronavirus pandemic 2019-2020 illustrated not only the high aggressiveness of the new infectious agent, moreover its capacity to cause severe cardiovascular complications. During the course of the coronavirus infection, it is possible to develop not only pulmonary, but also other neurological complications. Some symptoms experienced by some people weeks to months after COVID infection suggest the peripheral nervous system, the vast communication network that sends signals between the central nervous system (the brain and spinal cord) and all other parts of the body, is impaired. Objective: To evaluate the clinical and neurological characteristics of patients with polyneuropathies of coronavirus etiology. Methods: The study included 62 patients with polyneuropathies, the main group of 32 patients with polyneuropathies who underwent coronavirus disease and 30 patients with polyneuropathies. The results obtained: At the time of inclusion in the study, patients' complaints were dominated by sensory disturbances, signs of numbness, weakness and decreased performance in 97% of patients in the main group and 95% of the comparison group. Conclusion: The conducted clinical and neurological analysis shows that with polyneuropathy there is an increase in neurological symptoms after suffering a coronavirus disease and requires targeted tactics for the introduction and complex treatment of patients.